Mark Costanzo

As president of Renal Therapies Group, Mark Costanzo oversees renal products and pharmaceutical operations, including sales, marketing, the Renal Research Institute, medical and regulatory affairs, and Mexico and Canada operations. He assumed this position in January 2010. 

Mark joined Fresenius Medical Care in 1990 and has held several positions  including vice president, Peritoneal Dialysis Products, and vice president, sales and marketing. He began his career in the renal industry more than thirty years ago with Baxter International.